Treatment of Neuroendocrine Tumours: Approach of GEP-NETS
Canadian Oncology Today · 2025
DOI: 10.58931/cot.2025.2237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Oncology Today, 2025. Verfasst von Nathalie Baudoux und 1 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Neuroendocrine tumours (NETs) represent a rare entity, with various anatomic primary tumour sites, three different grades, a functional or non-functional status, and differences in somatostatin receptor expression, making NETs a heterogeneous disease. The management of these tumours is challenging and varies from a simple watch-and-wait strategy to more complex multi-modality treatment combinations. The choice of treatments depends on the previously mentioned factors. NETs most frequently arise from the gastro-entero-pancreatic (GEP) tract. The article reviews the classification, diagnosis, and staging of well-differentiated GEP-NETs, and discusses different therapeutic options.
Zitieren
APA
Baudoux, N., & Tehfe, M. (2025). Treatment of Neuroendocrine Tumours: Approach of GEP-NETS. Canadian Oncology Today. https://doi.org/10.58931/cot.2025.2237
Vancouver
Baudoux N, Tehfe M. Treatment of Neuroendocrine Tumours: Approach of GEP-NETS. Canadian Oncology Today. 2025. doi:10.58931/cot.2025.2237
BibTeX
@article{Baudoux2025,
author = {Baudoux, Nathalie and Tehfe, Mustapha},
title = {Treatment of Neuroendocrine Tumours: Approach of GEP-NETS},
journal = {Canadian Oncology Today},
year = {2025},
doi = {10.58931/cot.2025.2237}
}
EUVIMED